[Federal Register Volume 62, Number 92 (Tuesday, May 13, 1997)]
[Notices]
[Page 26345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-12489]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Office of the Secretary


Reports, Forms and Recordkeeping Requirements; Agency Information 
Collection Activity Under OMB Review

AGENCY: Office of the Secretary, DOT.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (44 U.S.C. 3501 
et seq.), this notice announces that the Information Collection Request 
(ICR) abstracted below has been forwarded to the Office of Management 
and Budget (OMB) for extension of currently approved collections. The 
ICR describes the nature of the information collection and its expected 
burden. The Federal Register Notice with a 60-day comment period 
soliciting comments on the following collection of information was 
published on February 11, 1997 [62 FR 6300].

DATES: Comments must be submitted on or before June 12, 1997.

FOR MORE INFORMATION CONTACT: Sylvia Barney, (202) 366-6680 and refer 
to the OMB Control Number.

SUPPLEMENTARY INFORMATION:

Federal Transit Administration (FTA)

    Title: Prevention of Prohibited Drug Use in Transit Operations.
    Type of Request: Extension to a currently approved information 
collection.
    OMB Control Number: 2132-0556.
    Form(s): N/A.
    Affected Public: Business or other for-profit, State, local 
government, and small business organizations.
    Abstract: The Omnibus Transportation Employee Testing Act of 1991 
(Pub. L. 102-143, October 28, 1991, now codified in relevant part 49 
U.S.C. 5331) requires any recipient of Federal financial assistance 
under 49 U.S.C. Sections 5309, 5307 or 5311 or under 23 USC Section 
103(e)(4) to establish a program designed to help prevent accidents and 
injuries resulting from safety-sensitive functions. FT's regulation, 49 
CFR part 653, ``Prevention of Prohibited Drug Use in Transit 
Operations,'' effective March 17, 1994, requires recipients to submit 
to FTA annual reports containing data which summarize information 
concerning the recipients' drug testing program, such as the number and 
type of tests given, number of positive test results, and the kinds of 
safety-sensitive functions the employees perform. FTA uses these data 
to ensure compliance with the rule, to assess the misuse of drugs in 
the transit industry, and to set the random testing rate. The data will 
also be used to assess the effectiveness of the rule in reducing the 
misuse of drugs among safety-sensitive transit employees and making 
transit safer for the public.
    Estimated Annual Burden: The annual estimated burden is 39,569 
hours.

ADDRESSES: Send comments to the Office of Information and Regulatory 
Affairs, Office of Management and Budget, 725-17th Street, NW., 
Washington, DC 20503, Attention FTA Desk Officer.
    Comments are Invited on: whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the Department, including whether the information will have practical 
utility; the accuracy of the Department's estimate of the burden of the 
proposed information collection; ways to enhance the quality, utility 
and clarity of the information to be collected; and ways to minimize 
the burden of the collection of information on respondents, including 
the use of automated collection techniques or other forms of 
information technology.

    Issued in Washington, DC, on May 7, 1997.
Phillip A. Leach,
Clearance Officer, United States, Department of Transportation.
[FR Doc. 97-12489 Filed 5-12-97; 8:45 am]
BILLING CODE 4910-62-P